Elevated Lipoprotein(a) Is Associated With Heart Failure in Patients With Peripheral Artery Disease.
文献摘要
Background The prognostic value of lipoprotein(a) [Lp(a)] in peripheral artery disease (PAD) remains uncertain. Methods and results We retrospectively studied 138 patients with intermittent claudication undergoing endovascular therapy. Patients were classified by Lp(a) level (≥30 vs. Conclusions Elevated Lp(a) was associated with heart failure-driven MACE after endovascular therapy in patients with PAD.